Fig. 1 | Scientific Reports

Fig. 1

From: Proteomic profiling of cerebrospinal fluid reveals TKT as a potential biomarker for medulloblastoma

Fig. 1

Flow chart illustrating the design of the present study. After discovery proteomics with LC‒MS/MS, one arm represents the process of label-free quantification and DEPs. The other arm represents feature selection with ANOVA and FCBF, with a validation process using ELISA and ExoView methods. Then, enrichment and pathway analyses of the TKT protein were performed, which appears to be a potential biomarker with various methodologies.

Back to article page